PDS Biotechnology Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

PDS Biotechnology Corp reported Cash And Cash Equivalents At Carrying Value of $26.71 million for the year ending 2025.

  • PDS Biotechnology Corp showed a decrease of -35.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from PDS Biotechnology Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2011 to 2025), PDS Biotechnology Corp's Cash And Cash Equivalents At Carrying Value has grown by 18,853.7%.
  • Historical annual values: Fiscal year 2025: $26.71 million | Fiscal year 2024: $41.69 million | Fiscal year 2023: $56.56 million | Fiscal year 2022: $73.82 million | Fiscal year 2021: $65.24 million | Fiscal year 2020: $28.84 million | Fiscal year 2019: $12.16 million | Fiscal year 2018: $103.7 thousand | Fiscal year 2017: $88.07 million | Fiscal year 2016: $106.40 million | Fiscal year 2015: $130.19 million | Fiscal year 2014: $13.73 million | Fiscal year 2013: $7.86 million | Fiscal year 2011: $140.9 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: